Nonprescription survey
This article was originally published in The Tan Sheet
Executive Summary
Ten percent of adults have taken one or more OTC products for a perceived cardiovascular health benefit, according to a survey published in the January American Journal of Preventive Medicine. Of those participants, 52.1% reported taking aspirin, 24.4% took vitamin E, 9.8% relied on garlic, and 3.8% took omega-3/fish oils/fatty acids, Margaret Artz, PhD, Department of Pharmaceutical Health Care & Health Systems, University of Minnesota, et al., report. Researchers used the 2000-2002 Minnesota Heart Survey to evaluate the vitamin, nonvitamin and OTC habits of 3,128 adults; at the time, vitamin E was the "dominant single-source vitamin" taken for CVH, though recent negative media reports have diminished the vitamin's reputation (1"The Tan Sheet" Nov. 15, 2004, p. 13). OTC product use was higher in participants over age 55 compared to younger age groups, the authors note. Almost one quarter (22%) of the 613 people using an Rx drug for CV reasons reported also taking OTC medications...
You may also be interested in...
Vitamin E Dose Increases Linked To Rise In Risk Of Death – Study
Negative results from a vitamin E study showing high doses of the supplement may lead to a greater risk of all-cause mortality increase industry anticipation of findings from ongoing prospective antioxidant trials
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.
How Ochre Bio Bagged Boehringer For Its RNA-Based Regenerative MASH Therapies
UK-based Ochre Bio has signed its first major deal with Boehringer Ingelheim. Scrip talked to its co-founder and CEO, Jack O’Meara, about its human tissue-based drug discovery platform, its resulting RNA platform for liver disease and how the fledgling drug company's early work mirrored that seen in diagnostics.